How Can This Cannabis Gum Cure Irritable Bowel Syndrome?
Is it True that Cannabis Gum can cure this disease? Scientific and medical professionals all agree that irritable bowel syndrome (IBS) could have a “brain-gut connection”. What does that actually mean? It means that depression and anxiety may cause IBS, with one constantly fueling the other. The potential solution? Marijuana-infused chewing gum could resolve this problem!
Around 3.5 million people in USA experience IBS. Cannabis Gum could be a solution!
It’s been known that cannabidiol (CBD), a non-psychoactive cannabinoid with anti-inflammatory properties, has shown promise in treating IBS. So, it’s no surprise that arrived a CBD-derived pharmaceutical intended for IBS treatment.
Medical researchers from Netherlands will begin testing CBD-infused gum made by Medical Marijuana, Inc., a San Diego, California company. Now people know this company for touting hemp-derived CBD oil.
The lab tests for “CanChew” will be the first time CBD’s efficacy as an IBS treatment will undergo lab testing. This is huge because IBS currently has no proven cure.
CBD could reduce the severity and frequency of colon spasms that afflict IBS sufferers. If the tension in the digestive tract is reduced, it could reduce bloating, cramping. It will allow an IBS sufferer to perform bowel movements.
In each piece of gum there’s 50 milligrams of CBD. Forty patients with IBS, age from 18 – 65, will receive the gum, with other study participants receiving a placebo. Participants will have the permission for up to six pieces of gum per day. That will help control their IBS symptoms.
AXIM, medical marijuana’s investment arm, believes that the CBD gum could be effective in treating other GI diseases like Crohn’s disease and colitis. That would be a big deal for a lot of people because Crohn’s is particularly horrible.
It remains unclear when this cannabis gum would make its way to American shores and into the hands of IBS patients. AXIM says it’s ready to launch straight into a second round of clinical trails if the gum does well in the Netherlands.